Pricing Log in Create free account
Friday 6 November 2026 Export LQDA’s income statement to Excel — free account

Liquidia Corporation

LQDA Healthcare Drug Manufacturers Specialty & Generic

Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.

Revenue
+1,842.7%
EPS
+271.4%
Free cash flow
+270.2%
Total debt
−9.04%

Quarter to June 2026, against a year earlier

44.63 0.14 +0.31%
Market cap
$4.0B
P/E
28.5×
Fwd P/E
22.1×
Dividend yield
—
F-score
5/9
Altman Z
4.08
Beneish M
6.79
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Liquidia Corporation (LQDA) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Liquidia Corporation (LQDA) trades at a EV/EBITDA of 22.7×. Over the past ten years it has ranged from 0.0× (March 2026) to 145× (June 2026); the current reading is higher than 94% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 12.2× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 41.0× (41.04%)
Mar 2026 69.5× —
Dec 2025 0.0× —
Sep 2025 0.0× —
25 more quarters

Against its own ten years

Low 0.0× High 145×
Ten-year median 0.0×
Current reading's percentile 94

EV/EBITDA against peers

Company EV/EBITDA
HIMS Hims & Hers Health, Inc. compare n/m
AMLX Amylyx Pharmaceuticals, Inc. compare n/m
HCM HUTCHMED (China) Limited Sponsored ADR compare 0.4×
RGC Regencell Bioscience Holdings Limited compare 1.1×
SUPN Indivior Pharmaceuticals Inc. compare 7.0×
PBH Prestige Consumer Healthcare Inc. compare 12.4×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 14.3×
LNTH Lantheus Holdings, Inc. compare 16.7×
LQDA Liquidia Corporation 22.7×
Drug Manufacturers Specialty & Generic industry median 12.2×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on LQDA